Inflammatory bowel disease (IBD) is an independent risk factor for serious infection, even at very low levels of gastrointestinal inflammation.
Latest data of InnoCare’s ICP-332 for the Treatment of Atopic Dermatitis Presented at LBA Session of 2024 AAD – Biotech Investments
EQS Newswire / 11/03/2024 / 09:00 UTC+8 Latest data of InnoCare’s ICP-332 for the Treatment of Atopic Dermatitis Presented at LBA Session of 2024